Corporate Governance in India: Issue and Challenges
Himalayan Journal of Economics and Business Management · 05.01.2026 · 07 (01) · 1-1
DOI: 10.47310/hjebm.2026.v07i01.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Himalayan Journal of Economics and Business Management, online erschienen am 05.01.2026. Verfasst von Neeraj Saini.
Abstract (Originalsprache)
Corporate governance is a broad term in a business environment. Corporate governance deals with mechanism by which stakeholder of a corporation exercise control our corporate insides management such that their interests are protected. In a company the separation of ownership and management is the distinct division between the company owners and the professional managers who run its day-to-day operations and make key decisions. This structure promotes professional management sustainability and efficiently by allowing specialists to run the business while the owner focuses on investing. However, it can lead to agency problems where managers internally diverge from those of stakeholders creating a need for corporate governance mechanisms like broad oversight and performance base compensation to align their goal. In this paper we will study the concept ,4Ps principles of corporate governance along with its significance from viewpoint of India. Then then we will discuss various issues and challenges related to corporate governance.
Zitieren
APA
Saini, N. (2026). Corporate Governance in India: Issue and Challenges. Himalayan Journal of Economics and Business Management, 07(01), 1-1. https://doi.org/10.47310/hjebm.2026.v07i01.003
Vancouver
Saini N. Corporate Governance in India: Issue and Challenges. Himalayan Journal of Economics and Business Management. 2026;07(01):1-1. doi:10.47310/hjebm.2026.v07i01.003
BibTeX
@article{Saini2026,
author = {Saini, Neeraj},
title = {Corporate Governance in India: Issue and Challenges},
journal = {Himalayan Journal of Economics and Business Management},
year = {2026},
volume = {07},
number = {01},
pages = {1--1},
doi = {10.47310/hjebm.2026.v07i01.003}
}
EUVIMED